[1]
Indolfi, P., Corbacioglu, S., Perrotta, S., Rossi, F., Marte, A., Pota, E., Martino, M., Pinto, D., Indolfi, C. and Casale, F. 2018. Targeted molecular therapy (modified RIST regimen) in relapsed high risk stage IV neuroblastoma: two cases report. Theory and Clinical Practice in Pediatrics. 2, 1 (Jan. 2018), 29-31. DOI:https://doi.org/10.25082/TCPP.2018.01.002.